RISS is an Australian not-for-profit company which manages national investments in research infrastructure.

Our aims relate to development of both cell therapy research and related infrastructure. We provide funds to enable these activities and we engage a range of stakeholders including universities, research institutions, hospitals and both State and Federal governments.

The company is funded by the Australian Federal Government’s Department of Innovation Industry Science and Research (DIISR) under the National Collaborative for Research Infrastructure Strategy (NCRIS) over five years ending in June 2011. More information is available on RISS by clicking on the following link - Advancing Cellular Therapies in Australia.

RISS Videos


We offer grants to develop TGA cGMP compliant quality systems, to maintain the compliance at sites and to enable researchers to access these cGMP facilities.

There are currently several cell therapy facilities  that are cGMP-compliant and TGA-licensed.